Vectura Group plc announced a key leadership appointment to drive business development and growth as the Company continues with its strategy to become a leading inhalation specialist in the pharmaceutical services space. Mark Bridgewater has been appointed as Chief Commercial Officer, a newly-created role focused on helping the Company to transform into a successful contract development and manufacturing organisation (CDMO). In his new position, Mr. Bridgewater will implement strong sales processes in order to secure new business, as well as building out a world-class commercial team and driving Vectura's brand market presence. Mr. Bridgewater has more than 20 years of experience in medical device and pharmaceutical services. Prior to joining Vectura, he was VP Business Development and Account Management for Europe and Asia at Flex, a global design, engineering and manufacturing organisation.